Business

Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2026 Restricted Stock Incentive Plan

Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2026 Restricted Stock Incentive Plan

articleChengdu Easton Biopharmaceuticals Co., Ltd. Class AJune 9, 20263/news/publicity-explanation-and-verification-opinions-of-the-remuneration-and-appraisal-committee-of-the-board-of-directors-on-list-of-initially-granted-incentive-objects-in-the-2026-restricted-stock-incentive-plan-9
Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2026 Restricted Stock Incentive Plan

About this update from Chengdu Easton Biopharmaceuticals Co., Ltd. Class A

Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2026 Restricted Stock Incentive Plan The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Chengdu Easton Biopharmaceuticals Co., Ltd. Class A